Literature DB >> 18154615

Special regulatory T-cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm.

Ronald N Germain1.   

Abstract

In the early 1970s a spate of papers by research groups around the world provided evidence for a negative regulatory role of thymus-derived lymphocytes (T cells). In 1971, Gershon and Kondo published a seminal paper in Immunology entitled 'Infectious Immunological Tolerance' indicating that such negative regulation could be a dominant effect that prevented otherwise 'helpful' T cells from mediating their function. Over the next decade, suppressor T cells, as these negative regulatory cells became known, were intensively investigated and a complex set of interacting cells and soluble factors were described as mediators in this process of immune regulation. In the early 1980s, however, biochemical and molecular experiments raised questions about the interpretation of the earlier studies, and within a few years, the term 'suppressor T cell' had all but disappeared from prominence and research on this phenomenon was held in poor esteem. While this was happening, new studies appeared suggesting that a subset of T cells played a critical role in preventing autoimmunity. These T cells, eventually dubbed 'regulatory T cells', have become a major focus of modern cellular immunological investigation, with a predominance that perhaps eclipses even that seen in the earlier period of suppressor T cell ascendancy. This brief review summarizes the rise and fall of 'suppressorology' and the possibility that Tregs are a modern rediscovery of suppressor T cells made convincing by more robust models for their study and better reagents for their identification and analysis.

Entities:  

Mesh:

Year:  2008        PMID: 18154615      PMCID: PMC2433291          DOI: 10.1111/j.1365-2567.2007.02779.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  105 in total

1.  Suppression of hapten-specific antibody response by carrier-specific T cells.

Authors:  K Okumura; T Tada
Journal:  Nat New Biol       Date:  1973-10-10

2.  Carrier function in anti-hapten antibody responses. VI. Establishment of experimental conditions for either inhibitory or enhancing influences of carrier-specific cells on antibody production.

Authors:  D H Katz; W E Paul; B Benacerraf
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

3.  The involvement of LD- and SD-region differences in MLC and CML: a three-cell experiment.

Authors:  D J Schendel; B J Alter; F H Bach
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

4.  Enhanced immune responsiveness to a thymus-independent antigen early after adult thymectomy: evidence for short-lived inhibitory thymus-derived cells.

Authors:  R S Kerbel; D Eidinger
Journal:  Eur J Immunol       Date:  1972-04       Impact factor: 5.532

5.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

6.  Active suppression of immunoglobulin allotype synthesis. I. Chronic suppression after perinatal exposure to maternal antibody to paternal allotype in (SJL x BALB-c)F 1 mice.

Authors:  E B Jacobson; L A Herzenberg
Journal:  J Exp Med       Date:  1972-05-01       Impact factor: 14.307

7.  Regulation of lymphocyte responses in vitro. I. Regulatory effect of macrophages and thymus-dependent (T) cells on the response of thymus-independent (B) lymphocytes to endotoxin.

Authors:  M Yoshinaga; A Yoshinaga; B H Waksman
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

8.  Biological expressions of lymphocyte activation. II. Generation of a population of thymus-derived suppressor lymphocytes.

Authors:  R R Rich; C W Pierce
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

9.  Synergy among lymphoid cells mediating the graft-versus-host response. 3. Evidence for interaction between two types of thymus-derived cells.

Authors:  H Cantor; R Asofsky
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

10.  Separable populations of activated thymus-derived lymphocytes identified in two assays for cell-mediated immunity to murine tumor allografts.

Authors:  R E Tigelaar; R M Gorczynski
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Immunity, thyroid function and pregnancy: molecular mechanisms.

Authors:  Anthony P Weetman
Journal:  Nat Rev Endocrinol       Date:  2010-04-27       Impact factor: 43.330

Review 2.  Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target.

Authors:  Dorothy K Sojka; Yu-Hui Huang; Deborah J Fowell
Journal:  Immunology       Date:  2008-03-14       Impact factor: 7.397

Review 3.  Treg cells, life history, and diversity.

Authors:  Christophe Benoist; Diane Mathis
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-09-01       Impact factor: 10.005

Review 4.  Transcriptional and epigenetic networks of helper T and innate lymphoid cells.

Authors:  Han-Yu Shih; Giuseppe Sciumè; Amanda C Poholek; Golnaz Vahedi; Kiyoshi Hirahara; Alejandro V Villarino; Michael Bonelli; Remy Bosselut; Yuka Kanno; Stefan A Muljo; John J O'Shea
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

5.  Induction of self-antigen-specific Foxp3+ regulatory T cells in the periphery by lymphodepletion treatment with anti-mouse thymocyte globulin in mice.

Authors:  Yan Lu; Jun Suzuki; Maria Guillioli; Oliver Umland; Zhibin Chen
Journal:  Immunology       Date:  2011-06-29       Impact factor: 7.397

Review 6.  Double negative (DN) αβ T cells: misperception and overdue recognition.

Authors:  Maria N Martina; Sanjeev Noel; Ankit Saxena; Hamid Rabb; Abdel Rahim A Hamad
Journal:  Immunol Cell Biol       Date:  2014-11-25       Impact factor: 5.126

7.  LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4+ regulatory T cell subpopulations mediated by 3G11 and CD127.

Authors:  Fang Zhou; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

8.  Exquisite selectivity for human toll-like receptor 8 in substituted furo[2,3-c]quinolines.

Authors:  Hari Prasad Kokatla; Diptesh Sil; Subbalakshmi S Malladi; Rajalakshmi Balakrishna; Alec R Hermanson; Lauren M Fox; Xinkun Wang; Anshuman Dixit; Sunil A David
Journal:  J Med Chem       Date:  2013-08-15       Impact factor: 7.446

9.  Human CD4low CD25high regulatory T cells indiscriminately kill autologous activated T cells.

Authors:  Ewa Bryl; Agnieszka Daca; Agnieszka Jóźwik; Jacek M Witkowski
Journal:  Immunology       Date:  2008-11-07       Impact factor: 7.397

Review 10.  Manipulation of regulatory T cells and antigen-specific cytotoxic T lymphocyte-based tumour immunotherapy.

Authors:  Shirin Karimi; Subhasis Chattopadhyay; Nitya G Chakraborty
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.